Related Experiment Videos
Acute otitis media and pneumococcal resistance: making judicious management decisions
1Family Nurse Practitioner Program, University of New Mexico College of Nursing, USA.
Abstract:
The emergence of drug-resistant Streptococcus pneumoniae (DRSP) has implications for the primary care provider who treats acute otitis media (AOM) in children. AOM must be carefully distinguished from otitis media with effusion (OME). Antibiotic treatment for AOM is recommended because of the low rate of spontaneous resolution of S. pneumoniae infection and the risk of suppurative complications, particularly in young children. Amoxicillin continues to be the first drug of choice. Children for whom the first course of antibiotics fails should be treated with amoxicillin-clavulanate, cefuroxime axetil, or ceftriaxone. Trimethoprim-sulfamethoxazole, the macrolides, and most of the cephalosporins have limited effectiveness against DRSP and should no longer have a major role in AOM treatment. OME need not be treated with antibiotics unless the effusion has been present for 3 to 4 months. Tympanostomy tubes are an effective treatment for both chronic OME and recurrent AOM. Given the significant increase of DRSP during the past decade, clinicians must minimize antibiotic use and, when antibiotics are required, make judicious clinical decisions.
Insights
Drug-resistant Streptococcus pneumoniae (DRSP) complicates childhood acute otitis media (AOM) treatment. Amoxicillin remains first-line, with alternatives for treatment failure, while some antibiotics are ineffective against DRSP.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Emergence of drug-resistant Streptococcus pneumoniae (DRSP) poses challenges for treating pediatric acute otitis media (AOM).
- Distinguishing AOM from otitis media with effusion (OME) is critical for appropriate management.
- Antibiotic therapy for AOM is often necessary due to low spontaneous resolution rates and risk of complications.
Purpose of the Study:
- To provide guidance on managing pediatric AOM in the context of rising DRSP.
- To outline appropriate antibiotic choices for AOM and OME.
- To emphasize judicious antibiotic use in pediatric otitis media.
Main Methods:
- Review of current literature and clinical guidelines on pediatric AOM and DRSP.
- Analysis of antibiotic efficacy against DRSP.
- Recommendations for first-line and alternative treatments for AOM.
Main Results:
- Amoxicillin is the recommended first-line treatment for AOM.
- Amoxicillin-clavulanate, cefuroxime axetil, or ceftriaxone are alternatives for treatment failures.
- Trimethoprim-sulfamethoxazole, macrolides, and some cephalosporins show limited effectiveness against DRSP and are not recommended for primary AOM treatment.
- Antibiotics are generally not indicated for OME unless effusion persists for 3-4 months.
- Tympanostomy tubes are effective for chronic OME and recurrent AOM.
Conclusions:
- Clinicians must be aware of DRSP prevalence when treating pediatric AOM.
- Judicious antibiotic selection and minimized antibiotic use are essential.
- Treatment strategies should differentiate between AOM and OME, with specific recommendations for each.